ALKBH5 and intrahepatic cholangiocarcinoma: In intrahepatic cholangiocarcinoma (ICC), the loss of ALKBH5 enhanced m6A abundances of PD-L1 transcripts in the 3′-UTR region in a YTHDF2-dependent manner (132), downregulating its expression.